This company has been acquired
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Atrion Inkomsten in het verleden
Verleden criteriumcontroles 1/6
Atrion's earnings have been declining at an average annual rate of -11.4%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 3.8% per year. Atrion's return on equity is 5.3%, and it has net margins of 6.9%.
Belangrijke informatie
-11.4%
Groei van de winst
-10.3%
Groei van de winst per aandeel
Medical Equipment Groei van de industrie | 8.9% |
Inkomstengroei | 3.8% |
Rendement op eigen vermogen | 5.3% |
Nettomarge | 6.9% |
Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
There May Be Some Bright Spots In Atrion's (NASDAQ:ATRI) Earnings
May 22Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading
Mar 24Subdued Growth No Barrier To Atrion Corporation (NASDAQ:ATRI) With Shares Advancing 25%
Mar 23Here's Why Atrion (NASDAQ:ATRI) Can Manage Its Debt Responsibly
Feb 09Atrion Corporation's (NASDAQ:ATRI) 26% Share Price Surge Not Quite Adding Up
Jan 04Atrion (NASDAQ:ATRI) Seems To Use Debt Quite Sensibly
Sep 14Atrion (NASDAQ:ATRI) Will Want To Turn Around Its Return Trends
Jul 18Be Wary Of Atrion (NASDAQ:ATRI) And Its Returns On Capital
Apr 19Atrion (NASDAQ:ATRI) May Have Issues Allocating Its Capital
Oct 18Atrion: Attractively Priced For Exposure To Defensive Healthcare
Sep 08Atrion's (NASDAQ:ATRI) Upcoming Dividend Will Be Larger Than Last Year's
Aug 27Atrion raises dividend 10.3% to $2.15/share
Aug 22Some Investors May Be Worried About Atrion's (NASDAQ:ATRI) Returns On Capital
Jul 18Atrion (NASDAQ:ATRI) Could Be Struggling To Allocate Capital
Jan 03Atrion's (NASDAQ:ATRI) Dividend Will Be Increased To US$1.95
Nov 18Atrion's (NASDAQ:ATRI) Dividend Will Be Increased To US$1.95
Sep 03Opbrengsten en kosten
Hoe Atrion geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 182 | 13 | 37 | 6 |
31 Mar 24 | 177 | 19 | 32 | 7 |
31 Dec 23 | 169 | 19 | 33 | 7 |
30 Sep 23 | 169 | 21 | 33 | 6 |
30 Jun 23 | 171 | 27 | 32 | 6 |
31 Mar 23 | 176 | 30 | 32 | 6 |
31 Dec 22 | 184 | 35 | 31 | 6 |
30 Sep 22 | 181 | 35 | 31 | 6 |
30 Jun 22 | 179 | 34 | 31 | 6 |
31 Mar 22 | 173 | 34 | 29 | 6 |
31 Dec 21 | 165 | 33 | 28 | 6 |
30 Sep 21 | 157 | 32 | 26 | 6 |
30 Jun 21 | 148 | 31 | 25 | 6 |
31 Mar 21 | 143 | 31 | 24 | 5 |
31 Dec 20 | 148 | 32 | 25 | 6 |
30 Sep 20 | 150 | 33 | 25 | 6 |
30 Jun 20 | 155 | 35 | 25 | 5 |
31 Mar 20 | 157 | 36 | 25 | 6 |
31 Dec 19 | 155 | 37 | 25 | 5 |
30 Sep 19 | 156 | 36 | 25 | 5 |
30 Jun 19 | 156 | 36 | 25 | 5 |
31 Mar 19 | 155 | 35 | 25 | 5 |
31 Dec 18 | 152 | 34 | 25 | 6 |
30 Sep 18 | 152 | 35 | 25 | 6 |
30 Jun 18 | 150 | 34 | 24 | 6 |
31 Mar 18 | 147 | 35 | 24 | 6 |
31 Dec 17 | 147 | 37 | 24 | 6 |
30 Sep 17 | 146 | 34 | 23 | 6 |
30 Jun 17 | 146 | 33 | 23 | 6 |
31 Mar 17 | 146 | 31 | 22 | 7 |
31 Dec 16 | 143 | 28 | 22 | 7 |
30 Sep 16 | 143 | 28 | 22 | 6 |
30 Jun 16 | 142 | 28 | 22 | 6 |
31 Mar 16 | 144 | 28 | 22 | 6 |
31 Dec 15 | 146 | 29 | 22 | 6 |
30 Sep 15 | 146 | 29 | 22 | 7 |
30 Jun 15 | 145 | 29 | 22 | 6 |
31 Mar 15 | 143 | 28 | 22 | 6 |
31 Dec 14 | 141 | 28 | 22 | 5 |
30 Sep 14 | 140 | 28 | 22 | 5 |
30 Jun 14 | 137 | 28 | 22 | 5 |
31 Mar 14 | 135 | 27 | 21 | 4 |
31 Dec 13 | 132 | 27 | 21 | 4 |
30 Sep 13 | 129 | 26 | 20 | 4 |
Kwaliteitswinsten: ATRI has high quality earnings.
Groeiende winstmarge: ATRI's current net profit margins (6.9%) are lower than last year (15.9%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: ATRI's earnings have declined by 11.4% per year over the past 5 years.
Versnelling van de groei: ATRI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: ATRI had negative earnings growth (-53.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (5.5%).
Rendement op eigen vermogen
Hoge ROE: ATRI's Return on Equity (5.3%) is considered low.